Dr. Darrell O. Ricke is a multidiscipline research scientist. His research pursuits include human disease research (including Kawasaki’s Disease), infectious diseases, vaccines, advanced DNA forensics, bioinformatics/computational biology, and artificial intelligence. Ricke has recently published SARS-CoV-2/COVID-19 research on clinical treatment, early cardiac pathology, etiology of multisystem inflammatory syndrome in children and adults, etiology of Kawasaki Disease, antibody dependent enhancement (ADE), and safety signals associated with specific vaccines. Ricke was a member of a finalist team for the 2023 Robert J. Collier Trophy. Ricke's DNA forensics solutions were a 2018 R&D 100 winner and a 2021 R&D 100 finalist, as well as a 2018 MIT Lincoln Laboratory Best Invention. Ricke has 12 patents, including influenza vaccine, complex DNA mixture analysis, Familial Mediterranean Fever (FMF) gene, etc. Ricke received a PhD degree in molecular biology from the Mayo Graduate School, a BS degree in genetics and cell biology and BS and MS degrees in computer science from the University of Minnesota.